HomeERMA • STO
add
Enorama Pharma AB
Previous close
kr 1.45
Day range
kr 1.00 - kr 1.50
Year range
kr 0.40 - kr 3.58
Market cap
78.32M SEK
Avg Volume
70.10K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | -193.00K | -102.58% |
Operating expense | 11.07M | 28.17% |
Net income | -13.35M | -87.26% |
Net profit margin | 6.92K | 7,358.35% |
Earnings per share | — | — |
EBITDA | -12.34M | -181.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.56M | -31.76% |
Total assets | 12.57M | -69.74% |
Total liabilities | 17.22M | 120.05% |
Total equity | -4.65M | — |
Shares outstanding | 74.59M | — |
Price to book | -24.17 | — |
Return on assets | -164.27% | — |
Return on capital | -1,699.12% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -13.35M | -87.26% |
Cash from operations | -12.02M | -22.79% |
Cash from investing | — | — |
Cash from financing | 15.64M | 33,387.23% |
Net change in cash | 4.05M | 152.15% |
Free cash flow | -7.02M | 1.92% |
About
Founded
2006
Website
Employees
5
